Citi raises AMD and Nvidia price targets — Positive

AMD  NVDA   Finbold — July 07, 2025

Citi are feeling more bullish about semiconductors, lifting their price targets for Nvidia (NASDAQ: NVDA) and AMD as the AI race intensifies.

image for news Citi raises AMD and Nvidia price targets

Artificial intelligence hyperscaler CoreWeave said Monday it will acquire Core Scientific, a leading data center infrastructure provider. It is an all-stock deal valued at approximately $9 billion.

image for news CoreWeave to acquire Core Scientific in $9 billion all-stock deal

Locafy Launches AI-Driven SEO Product Suite for FY26 — Neutral

LCFY   GlobeNewsWire — July 07, 2025

Locafy's AI Search Platform Powers Visibility Across Organic and AI Search New Product Lineup Tailored to Local, National, and e-Commerce Businesses

image for news Locafy Launches AI-Driven SEO Product Suite for FY26

CVS Health declares quarterly dividend — Neutral

CVS   PRNewsWire — July 07, 2025

WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

image for news CVS Health declares quarterly dividend

Expedia: No Market Respect Yet — Positive

EXPE   Seeking Alpha — July 07, 2025

I maintain a Strong Buy rating on Expedia Group, Inc. with a $400 YE26 price target, citing deep value and strong cash earnings growth. Expedia's shift toward the merchant model boosts margins and cash flow, despite higher business risk, while maintaining an asset-light structure. EXPE stock trades at a significant valuation discount to peers like Booking and Airbnb, despite comparable or superior growth prospects and robust free cash flow.

image for news Expedia: No Market Respect Yet

DFAU: A Small-Cap Value Tilt Won't Move The Needle — Negative

DFAU   Seeking Alpha — July 07, 2025

DFAU offers broad U.S. equity exposure with a modest tilt to undervalued, profitable small caps, but closely tracks S&P 500 performance. Short-term macro challenges—slowing growth, rising unemployment risk, and inflation—may create opportunity costs for equity investors. Despite market optimism and strong equity allocations, high valuations and persistent macro risks warrant a cautious approach for now.

image for news DFAU: A Small-Cap Value Tilt Won't Move The Needle

Tesla investors becoming 'exhausted' by Musk's political machinations — Negative

TSLA   Proactive Investors — July 07, 2025

There is a sense of 'exhaustion' among Tesla Inc (NASDAQ:TSLA) investors as Elon Musk continues to head down the political track. That is the conclusion of analysts at Wedbush after the CEO launched a new “America Party” on X, diverting attention from the electric-vehicle maker's core business.

image for news Tesla investors becoming 'exhausted' by Musk's political machinations

Bit Digital becomes one of the largest public Ethereum holders — Positive

BTBT   Proactive Investors — July 07, 2025

Bit Digital Inc (NASDAQ:BTBT) announced that it has completed the transition of its corporate treasury strategy to Ethereum (ETH), positioning the company among the largest public holders of ETH globally. Investors welcomed the update, sending shares of Bit Digital 18% higher shortly after US markets opened on Monday.

image for news Bit Digital becomes one of the largest public Ethereum holders

The news that Paramount settled with President Trump for $16 million over alleged 60 Minutes edits that Trump alleged favored then Vice President Kamala Harris prompted criticism from some in the media. When Harris was asked about the Biden administration's relationship with Israel's prime minister, CBS producers used different portions of her answer on two programs.

image for news Paramount Settles Trump Suit For $16M With President's No-Tax Playbook

– National Footprint of NEXICART-2 Trial Sites Expanded – – On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at ASCO 2025 – LOS ANGELES, CA, July 07, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced accelerated U.S. NEXICART-2 clinical trial progress in relapsed/refractory AL Amyloidosis. NEXICART-2 now includes 18 clinical trial sites in its national footprint.

image for news Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis

Hong Kong, July 07, 2025 (GLOBE NEWSWIRE) -- Top Win International Limited (Nasdaq: SORA), through its subsidiary, AsiaStrategy Topwin SG Pte. Ltd. (“AsiaStrategy”), has announced an intention to make a tender offer (the “Announcement”) with certain other offerors for the securities of DV8 Public Company Limited (SET: DV8), a company public listed on The Stock Exchange of Thailand (“DV8”).

image for news Top Win International (Nasdaq: SORA) Launches Voluntary Tender Offer for Thai Listed Company

Netflix Stock Stalled as Analyst Voices Valuation Concerns — Negative

NFLX   Schaeffers Research — July 07, 2025

Streaming favorite Netflix Inc (NASDAQ:NFLX) is down 1.1% to trade at $1,291.57, after suffering a downgrade to "neutral" from "buy" at Seaport Research Partners.

image for news Netflix Stock Stalled as Analyst Voices Valuation Concerns

VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd . (NASDAQ: FMST) (CSE: FAT) ("Foremost" or the "Company"), is pleased to announce plans to initiate a district-scale 5,000 line-kilometer MobileMT™ airborne geophysical survey across its GR (“GR”) and Blackwing (“Blackwing”) Uranium Properties, located in the world-renowned Athabasca Basin region of northern Saskatchewan. The survey, to be conducted by Expert Geophysics Surveys Inc, is designed to detect deep conductive structures prospective for hosting high-grade uranium mineralization. The program is expected to begin mid-July, subject to operational scheduling.

image for news Foremost Clean Energy to Deploy District-Scale MobileMT™ Survey Over its GR and Blackwing Uranium Properties

Does Capital One's Lower SCB Reflect Robust Capital Discipline? — Positive

COF   Zacks Investment Research — July 07, 2025

COF's lower SCB boosts capital flexibility, paving the way for growth investments, steady dividends, share repurchases and stronger returns.

image for news Does Capital One's Lower SCB Reflect Robust Capital Discipline?

Why National Grid Stock Deserves a Spot in Your Portfolio Right Now — Neutral

NGG   Zacks Investment Research — July 07, 2025

NGG is a strong investment choice, given its earnings growth estimates, consistent capital spending plan and large-scale renewable energy projects.

image for news Why National Grid Stock Deserves a Spot in Your Portfolio Right Now

Urges stockholders to vote “FOR” Mr. Vazquez and Carlos Minetti on the GREEN proxy card

image for news Oportun Board of Directors Reiterates Importance of CEO Raul Vazquez's Continued Stewardship on the Board

Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor — Positive

JAZZ   Seeking Alpha — July 07, 2025

In recent months, Jazz Pharmaceuticals plc has remained a stock that has seen some decline in attention from retail investors. This comes amid the potential approval of Zepzelca in combination with Tecentriq as a therapy for first-line extensive-stage small cell lung cancer. Meanwhile, the crown jewel of Jazz Pharmaceuticals' oncology franchise is Ziihera, which is superior in efficacy to chemotherapy drugs and Enhertu in the treatment of biliary tract cancer and more.

image for news Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor

MONSEY, N.Y., July 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Olo, Inc. (NYSE: OLO) (“Olo”) to Thoma Bravo for $10.25 per share in cash.

image for news OLO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Olo to Thoma Bravo

Amazon Vs. MercadoLibre: Comparing 2 Similar Growth Stocks — Neutral

AMZN  MELI   Seeking Alpha — July 07, 2025

Amazon and MercadoLibre are both distinguished growth stocks and leaders in the broadline retail business. Amazon's growth is helped by its AWS subsidiary and by astute marketing such as its highly successful Amazon Prime Day. MercadoLibre has a commanding position in Latin America where it copies many aspects of Amazon and has a long runway for growth.

image for news Amazon Vs. MercadoLibre: Comparing 2 Similar Growth Stocks

RISHON LE ZION, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC), a global integrator of supply chain technologies, today announced that it has secured orders totaling $425,000 from new customers in India.

image for news BOS Better Online Solutions Secures $425,000 in Orders from New Indian Customers